Bachem Holding AG (BCHMF)
Bachem Holding AG operates in the Biotechnology industry of the Healthcare sector, headquartered in Bubendorf, BL, CH. The stock last traded at $91.00, up 0.00% on the session, giving a market capitalisation of $6.82B. On trailing twelve-month figures it carries a trailing P/E of 40.85, a net margin of 21.0%. Its beta of 0.81 implies it has historically moved less than the broad market.
Bachem Holding AG is a global partner to pharmaceutical and biotechnology companies, supplying crucial products and services for every stage from early-stage research and clinical trials to full-scale commercialization. The company specializes in the creation, manufacturing, and regulatory assistance for peptide active pharmaceutical ingredients (APIs), particularly novel peptide and oligonucleotide chemical entities (NCEs). Beyond these, Bachem also offers established commercial NCEs and generic medications. Its comprehensive service offerings include project oversight, quality assurance, regulatory compliance guidance, advanced analytical testing, GMP-compliant production, specialized research-grade manufacturing, and integrated supply chain solutions. The company, established in 1971, operates from its headquarters in Bubendorf, Switzerland.
Bachem Holding AG is most often compared with the following Healthcare names: